✦ LIBER ✦

Steady-state levels of pefloxacin and its metabolites in patients with severe renal impairment

✍ Scribed by P. Jungers; D. Ganeval; T. Hannedouche; B. Prieur; G. Montay

Publisher: Springer
Year: 1987
Tongue: English
Weight: 569 KB
Volume: 33
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00544236

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steady-state pharmacokinetics of nefazod

Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function

✍ R. H. Barbhaiya; M. E. Brady; U. A. Shukla; D. S. Greene 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 604 KB

The steady-state pharmacokinetics of nefazodone (NEF) and its metabolites hydroxynefazodone (HO-NEF) and m-chlorophenylpiperazine (mCPP) were compared in subjects with normal and impaired renal function. Patients: The Study was of parallel group design which included 7 subjects with normal (NOR) ren

Felodipine in the treatment of patients

Felodipine in the treatment of patients with severe hypertension and impaired renal function

✍ R. Larsson; M. K. Lindsjö; B. Danielsson; U. Bengtsson; J. H. Hardlund; P. A. Sj 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 519 KB

Total and free steady-state plasma level

Total and free steady-state plasma levels and pharmacokinetics of nifedipine in patients with terminal renal failure

✍ L. Bortel; R. Böhm; J. Mooij; P. Schiffers; K. H. Rahn 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 600 KB

The disposition and protein binding of b

The disposition and protein binding of batanopride and its metabolites in subjects with renal impairment

✍ J. V.St. Peter; M. E. Brady; E. F. Foote; K. A. Dandekar; L. Smaldone; J. L. Pyk 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 519 KB

We have studied the disposition of batanopride and its three major metabolites (the erythro-alcohol, threo-alcohol, and N-desethyl metabolites) in 27 subjects with various degrees of renal function after intravenous infusion of a single dose of 3.6.mg.kg-1 of batanopride over 15 min. The subjects we

Tolerability and steady-state pharmacoki

Tolerability and steady-state pharmacokinetics of terodiline and its main metabolites in elderly patients with urinary incontinence

✍ B. Hallén; S. Bogentoft; S. Sandquist; S. Strömberg; G. Setterberg; E. Ryd-Kjell 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 883 KB

Pharmacokinetics of oral diltiazem and f

Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure

✍ Maha Tawashi; Julien Marc-aurèle; Daniel Bichet; Jean Spénard; Lyne Larivière; D 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

The pharmacokinetics of oral diltiazem were studied in 10 patients with chronic renal failure not requiring dialysis and in five healthy volunteers after a single dose of 120mg. We found that patients with chronic renal failure had lower amounts of unchanged diltiazem and of its main metabolite (MA)